Figure 2From: Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysisForest plots showing the efficacy of PZQ (30-60 mg/kg) for schistosomiasis treatment (RCTs). n/N = number examined as positive outcome (or not cured) over number of participants who were examined. Sub-groups with trials with patients infected by different Schistosoma species (01: S. haematobium, 02: S. mansoni, and 03: S. japonicum) were separately combined. The P value of each test for heterogeneity was ≥0.05, thus the fixed-effect model was used to combine trial-specific RRs of each sub-group and the total pooled RR, and its 95% CI were calculated by combing all sub-groups. No statistically significant difference among pooled RRs of sub-groups about different species was observed.Back to article page